USA. Rezenopy, the 10 Mg Naloxone Nasal Spray, Enters the OD Antidote Market Two years after its approval by the Food and Drug Administration, opioid-overdose reversal product Rezenopy is about to make its commercial launch. At 10 mg of naloxone pe…